IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Big Growth in CRAMS Contracts for Jubilant

1:44 PM MDT | April 4, 2007 | Chemical Week Editorial Staff

Jubilant Organosys (Noida), one of India’s largest drug discovery and pharma services companies, says it has signed several custom research and manufacturing services (CRAMS) contracts worth a combined $60 million. The value of the deals represents a 50% increase over deals signed last year. Jubilant says that almost $54 million worth of contracts are with European and U.S. firms, and include deals with unspecified life science multinationals. “We will continue to focus on investments in innovation and world-class manufacturing facilities,” says...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa